GT Biopharma, Inc.

New Filing
CIK: 0000109657·Biotechnology·FLORIDA·Filed: Sep 14, 2017
Total Offering

$4,540,000

Amount Sold

$4,540,000

Investors

9

First Sale

Aug 31, 2016

Offering Details

Type
Equity, Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Kathleen Clarence-Smith
Related Person
Anthony Cataldo
Related Person
Steven Weldon
Related Person

Company

GT Biopharma, Inc.

1825 K Street

Washington, DC, 20006

(800) 304-9888

SEC Filing

0000939798-17-000077

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free